Stay updated on Miransertib in Overgrowth Spectrum Clinical Trial
Sign up to get notified when there's something new on the Miransertib in Overgrowth Spectrum Clinical Trial page.

Latest updates to the Miransertib in Overgrowth Spectrum Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page’s displayed ClinicalTrials.gov release/version indicator was updated from “v3.5.2” to “v3.5.3.” This reflects a site revision rather than a change to the study details.SummaryDifference0.0%

- Check23 days agoChange DetectedRevision: v3.5.2 was applied, replacing v3.5.0.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision number updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check59 days agoChange DetectedRevision label on the page was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check88 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2, indicating an administrative update to the page's revision history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check95 days agoChange DetectedThe page now displays Revision: v3.4.1 and no longer shows Revision: v3.4.0, a minor metadata update that does not affect study details or functionality; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Miransertib in Overgrowth Spectrum Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Miransertib in Overgrowth Spectrum Clinical Trial page.